| Serial Number | 98741228 |
| Word Mark | BRIDGE PHARMA |
| Filing Date | Monday, September 9, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, March 19, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Scientific research and development of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 9, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bridgewest International Holdings LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Miami, FL 33131 |
| Event Date | Event Description |
| Monday, September 9, 2024 | NEW APPLICATION ENTERED |
| Tuesday, March 18, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 19, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, March 19, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 19, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 19, 2025 | NON-FINAL ACTION E-MAILED |